{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T02:10:20Z","timestamp":1758420620177,"version":"3.44.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS113828"],"award-info":[{"award-number":["R01NS113828"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jns.2022.120424","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T23:15:03Z","timestamp":1664579703000},"page":"120424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Improving myelopathy diagnosis now and into the future"],"prefix":"10.1016","volume":"442","author":[{"given":"Laura","family":"Cacciaguerra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eoin P.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2022.120424_bb0005","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1212\/WNL.0000000000004796","article-title":"Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses","volume":"90","author":"Zalewski","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2022.120424_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120425","article-title":"Identification of specific causes of myelopathy in a large cohort of patients initially diagnosed with transverse myelitis","volume":"442","author":"Murphy","year":"2022","journal-title":"J. Neurol. Sci."},{"issue":"9","key":"10.1016\/j.jns.2022.120424_bb0015","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/acn3.51642","article-title":"Seroprevalence of anti-myelin oligodendrocyte glycoprotein antibodies in adults with myelitis","volume":"9","author":"Kim","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jns.2022.120424_bb0020","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1212\/WNL.0000000000007828","article-title":"Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology","volume":"93","author":"Sechi","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2022.120424_bb0025","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1212\/WNL.0000000000004765","article-title":"Clinical biomarkers differentiate myelitis from vascular and other causes of myelopathy","volume":"90","author":"Barreras","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2022.120424_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116863","article-title":"Clinical characteristics, misdiagnosis and outcomes of patients with low-flow spinal arteriovenous fistulas","volume":"413","author":"Murphy","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2022.120424_bb0035","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000722","article-title":"Clinical and MRI phenotypes of sarcoidosis-associated myelopathy","volume":"7","author":"Murphy","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jns.2022.120424_bb0040","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1212\/CPJ.0000000000001036","article-title":"Utility of MRI enhancement pattern in myelopathies with longitudinally extensive T2 lesions","volume":"11","author":"Mustafa","year":"2021","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.jns.2022.120424_bb0045","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/WNL.59.4.499","article-title":"Transverse myelitis consortium working G. proposed diagnostic criteria and nosology of acute transverse myelitis","volume":"59","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2022.120424_bb0050","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.mayocp.2020.01.032","article-title":"Whole-body 18F-FDG PET-CT in the diagnosis of Neurosarcoidosis","volume":"95","author":"Fritz","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jns.2022.120424_bb0055","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/STROKEAHA.120.031482","article-title":"Serum Neurofilament to magnetic resonance imaging lesion area ratio differentiates spinal cord infarction from acute myelitis","volume":"52","author":"Sechi","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2022.120424_bb0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/RLI.0000000000000735","article-title":"Deep learning on conventional magnetic resonance imaging improves the diagnosis of multiple sclerosis mimics","volume":"56","author":"Rocca","year":"2021","journal-title":"Investig. Radiol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22002866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22002866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:02:24Z","timestamp":1758384144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X22002866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":12,"alternative-id":["S0022510X22002866"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2022.120424","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving myelopathy diagnosis now and into the future","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2022.120424","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120424"}}